IFNA1 and systemic lupus erythematosus: Patients with SCLE and DLE exhibit increased expression of type I IFN-regulated genes or the IFN signature in their peripheral blood, regardless of the presence/absence of concomitant SLE, which is correlated with their cutaneous disease activity [20].